17th Apr 2007 10:20
AGI Therapeutics plc17 April 2007 AGI Therapeutics plc ("AGI" or the "Company") Holding(s) in Company AGI was notified on 16 April 2007 that Merlin BioMed Group sold 350,000 and1,050,000 ordinary shares of €0.01 each on the 11 and 12 April 2007 respectivelyand therefore no longer has a notifiable interest in the share capital of theCompany. Contact Information AGI Therapeutics David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254 17 April 2007 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Potentially Ai